Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of low-dose colchicine in patients with ST elevation myocardial infarction at Surin Hospital
TCTR20210127005Phase 4Recruiting
- Sponsor
- Surin Hospital
- Start
- Jun 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in acute ST-segment elevation myocardial infarction (STEMI), sponsored by Surin Hospital. Started Jun 2020; status: recruiting.
02
Drugs
colchicine
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on TCTR20210127005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210127005.